Everything below concerns LC-MS/MS. We keep the language plain, cite what the science says, and separate well-supported claims from open questions.
Updated 2025-09-18. Numbers and descriptions here follow the published literature rather than marketing material.
Analytical laboratories typically identify cardarine and its metabolites using liquid chromatography-tandem mass spectrometry. Urine is a common matrix in anti-doping testing, while blood and tissue may be used in research settings. Detection windows depend on the assay, the sample matrix, and the compound's metabolism. Because cardarine is extensively metabolized, laboratories often target specific metabolites to improve sensitivity and confirmation. Reference standards are required for reliable quantification. Method validation includes checks for selectivity, linearity, and carryover.
A persistent misconception is that cardarine is a fat-burning drug or a safe alternative to anabolic steroids. No approved therapeutic product exists, and human safety data are limited. The tumor findings in rodents remain a central concern in scientific reviews. Products sold online may contain inaccurate labels, impurities, or different compounds entirely, which complicates any assessment of effects. Independent testing of such products has reported frequent mislabeling. For these reasons, discussions in the literature emphasize risks and unknowns rather than benefits.
Cardarine is not approved for human therapeutic use in any major jurisdiction. It appears on the World Anti-Doping Agency Prohibited List as a PPARδ agonist within the hormone and metabolic modulators category. Sports organizations test for it because it has been detected in athlete samples and seized products. Regulatory actions against marketed research chemical versions have occurred in several countries, though enforcement varies. Availability through unregulated channels complicates oversight.
Cardarine can be detected in biological samples and product materials using liquid chromatography coupled to tandem mass spectrometry (LC-MS/MS). The method separates compounds by chromatography and identifies them by mass-to-charge transitions, allowing low-level detection in urine or blood. Sample preparation often involves enzymatic hydrolysis, solid-phase extraction, or protein precipitation. Certified reference materials and isotope-labeled internal standards improve quantification. Detection windows depend on metabolism, matrix, and assay sensitivity, so no single universal window applies.
Regulatory treatment of cardarine differs by context and jurisdiction. In competitive sport, the World Anti-Doping Agency lists PPARδ agonists, including GW501516, as prohibited at all times. Outside sport, it lacks approval as a prescription medicine in major drug markets, and products sold for human consumption may be treated as unapproved drugs. Some countries also restrict importation or sale through general consumer protection and medicines laws. These classifications affect availability, testing, and legal risk without establishing therapeutic value.
Because cardarine is not an approved medicine, no pharmacopeial monograph defines its identity, purity, or storage requirements. Laboratories typically rely on in-house methods and reference standards when testing materials labeled as GW501516. Certificates of analysis may report purity and identity for a specific batch, but their scope varies and they do not guarantee safety or legal status. Independent verification can include high-performance liquid chromatography, mass spectrometry, nuclear magnetic resonance, and elemental analysis. The distinction between research chemical labeling and human use is significant because quality standards and oversight differ.
| Property | Value | Notes |
|---|---|---|
| Regulatory status | Not approved for human therapeutic use | No marketing authorization identified in major jurisdictions. |
| Anti-doping class | PPARδ agonist; hormone and metabolic modulators | Listed on the WADA Prohibited List. |
| Common test matrix | Urine | Also blood and tissue in research settings. |
| Typical analytical method | LC-MS/MS | Targets parent compound and metabolites. |
| Major safety signal | Tumor findings in rodents | Human relevance not established; limited human data. |
Stability of GW501516 depends on form, temperature, light exposure, and moisture. Solid reference material is typically stored frozen or refrigerated in a desiccator and protected from light. Solutions in organic solvents such as dimethyl sulfoxide are often kept frozen in aliquots to reduce freeze-thaw cycling. Aqueous solubility is low, so aqueous stock solutions can be difficult to prepare without cosolvents. Degradation may appear as changes in chromatographic purity or mass spectral signal. Stability studies are needed to establish shelf life for any specific preparation.
Quality assessment for cardarine samples usually combines identity, purity, and impurity testing. Nuclear magnetic resonance spectroscopy and mass spectrometry can confirm molecular structure, while high-performance liquid chromatography estimates purity. Certificates of analysis from testing laboratories may list these results, but they do not establish safety or legality. In the absence of approved manufacturing, products sold online may contain the wrong compound, variable amounts, or unlisted contaminants. Independent verification is therefore central to analytical work and to interpreting any reported biological activity.
Laboratory detection of GW501516 commonly uses liquid chromatography coupled with tandem mass spectrometry. The method can identify the parent compound or its metabolites in urine and blood after sample cleanup. Protein precipitation, solid-phase extraction, or enzymatic hydrolysis may precede analysis, depending on the matrix. Reference standards are required for accurate quantification and confirmation. Because the compound is not approved, testing often occurs in anti-doping, forensic, or research settings rather than routine clinical care. Results are reported with limits of detection and quantification.
Laboratory studies indicate that GW501516 activates PPARδ, a nuclear receptor involved in fatty acid oxidation and energy metabolism. In rodent experiments, treated animals often showed increased endurance and reduced fat mass. These effects were observed under controlled conditions and do not establish safe or effective use in humans. The exact dose-response relationship in humans remains poorly characterized. Species differences in metabolism can affect how results translate across animals and people.
Safety concerns emerged from long-term animal studies. In rodents given the compound for extended periods, researchers found an increased incidence of certain cancers, including liver and bladder tumors. These findings contributed to the discontinuation of clinical development. Whether similar risks apply to short-term or low-level exposure in humans is not established, and controlled human safety data are limited. The relevance of high-dose rodent carcinogenicity findings to human use remains a subject of debate.
Human trials of GW501516 were small and short in duration. They examined lipid levels, glucose handling, and other metabolic markers, but the programs were halted after the animal cancer findings. No approved therapeutic product exists, and published human data are insufficient for establishing long-term safety. Reports of use for athletic performance come mainly from non-clinical settings and cannot be verified through controlled trials. Independent testing of products sold as cardarine has found inconsistent purity and labeling.
Cardarine is a common name for GW501516, an investigational compound developed in the 1990s for metabolic conditions. It acts as an agonist at peroxisome proliferator-activated receptor delta, a nuclear receptor involved in lipid and energy metabolism. The compound is frequently mislabeled as a selective androgen receptor modulator, or SARM, but its molecular target is different. GW501516 reached early clinical testing before development was discontinued. It has no approved therapeutic use in any country. The name cardarine is not a formal international nonproprietary name.
Regulatory treatment varies, but cardarine is not approved as a medicine. Sports authorities list GW501516 as a prohibited substance, and it is banned at all times under the World Anti-Doping Agency code. Many countries restrict sales for human consumption, while online vendors market it as a research chemical. Such products may lack purity data, and their actual contents can differ from the label. Purchasing or possessing cardarine may carry legal consequences depending on jurisdiction. The compound is not a dietary supplement ingredient in regulated markets.
Clinical development stopped after rodent studies showed tumors at multiple sites. Whether those findings predict human cancer risk remains an open question, but they led sponsors to discontinue programs. Human safety data are limited to small, short-term studies that were not designed to assess cancer risk. Reported effects in those studies included changes in blood lipids, but the evidence is insufficient for medical use. Long-term consequences of nonmedical use are not well characterized. Questions about dose, duration, and individual susceptibility remain unresolved.
Overfishing of fish species targeted for their fish bladders has led to fish stock collapse. The first major population decline from the swim bladder trade was of the Chinese bahaba or giant yellow croaker Bahaba taipingensis of the China Seas. While Chinese bahaba fishing was banned for domestic trade in 1989 after the classification of the fish as Class II under the Wildlife Protection Law of the People's Republic of China, the Chinese bahaba population continued to decline and was added to the IUCN Red List in 2009. The totoaba began to be targeted for its perceived similarity to the Chinese bahaba by the 1920s, and increased in scope until it was categorized as a vulnerable species. On Lake Victoria, there is increased usage of illegal monofilament nets and targeting of undersized fish, impacting the Nile perch population. Kenya, Uganda and Tanzania have beach patrols and fishing regulations to regulate the fish maw trade.
== Role in hydrocarbon generation == When animal or plant matter is buried during sedimentation, the constituent organic molecules (lipids, proteins, carbohydrates and lignin-humic compounds) break down due to the increase in temperature and pressure. This transformation occurs in the first few hundred meters of burial and results in the creation of two primary products: kerogens and bitumens. It is generally accepted that hydrocarbons are formed by the thermal alteration of these kerogens (the biogenic theory). In this way, given certain conditions (which are largely temperature-dependent) kerogens will break down to form hydrocarbons through a chemical process known as cracking, or catagenesis. A kinetic model based on experimental data can capture most of the essential transformation in diagenesis, and a mathematical model in a compacting porous medium to model the dissolution-precipitation mechanism. These models have been intensively studied and applied in real geological applications. Diagenesis has been divided, based on hydrocarbon and coal genesis into: eodiagenesis (early), mesodiagenesis (middle) and telodiagenesis (late). During the early or eodiagenesis stage shales lose pore water, little to no hydrocarbons are formed and coal varies between lignite and sub-bituminous. During mesodiagenesis, dehydration of clay minerals occurs, the main development of oil genesis occurs and high to low volatile bituminous coals are formed. During telodiagenesis, organic matter undergoes cracking and dry gas is produced; semi-anthracite coals develop.
{\displaystyle {\text{CL}}\sim {\frac {sV_{e}V_{p}}{sV_{e}+V_{p}}}{\frac {k_{\text{deg}}}{k_{\text{on}}F_{0}}}\left({\frac {{\text{CL}}_{\text{up}}}{V_{e}}}+k_{\text{off}}\right){\frac {F_{0}}{F_{0}-sC_{p}^{\text{IgG}}}}.}
Sources: en.wikipedia.org
High oil prices also induced investment in oil production by non-OPEC countries, including Prudhoe Bay in Alaska, the North Sea offshore fields of the United Kingdom and Norway, the Cantarell offshore field of Mexico, and oil sands in Canada.
=== British Empire Medal (BEM) === Civil Division Dewitt Carey, . For services to the community. The Reverend Carlton Alexander Farquharson, . For services to the Island of Inagua. Rosie Grant. For services to the community. Eleazor James Johnson. For services to sailing. Captain Hezron Lenox Moxey. For services to sailing. Theophilus Neely, . For services to the community of South Andros. Lindsay Williamson. For services to the community. Mildred Williamson. For services to the community. Otis Young, . For services to South Eleurhera.
== External links == Official website Indian Council of Historical Research - Sudhir Chandra - Economic and Political Weekly, Vol. 7, No. 28 (Jul. 8, 1972), pp. 1311-1313 Society Name Search at www.delhi.gov.in
Wool Bradford, Halifax and Huddersfield grew through the development of woollen mills. Leeds' traditional industry was the manufacturing of cloth while heavier engineering industries facilitated growth in South Leeds. The Heavy Woollen District covered towns such as Dewsbury, Batley, Morley, Ossett, Cleckheaton and Heckmondwike. The woollen and cloth industries declined throughout the twentieth century.
Sources: en.wikipedia.org
=== Translation initiation === Protein synthesis is primarily regulated at the stage of translation initiation. In eukaryotes, the canonical initiation pathway requires at least 12 protein initiation factors, some of which are themselves large complexes. The structures of the 40S:eIF1 and 60S:eIF6 complexes provide first detailed insights into the atomic interactions between the eukaryotic ribosome and regulatory factors. eIF1 is involved in start codon selection, and eIF6 sterically precludes the joining of subunits. However, structural information on the eukaryotic initiation factors and their interactions with the ribosome is limited and largely derived from homology models or low-resolution analyses. Elucidation of the interactions between the eukaryotic ribosome and initiation factors at an atomic level is essential for a mechanistic understanding of the regulatory processes, but represents a significant technical challenge, because of the inherent dynamics and flexibility of the initiation complexes. The first structure of the mammalian pre initiation complex was done by cryo-electron microscopy. Other structures of initiation complexes followed soon, driven by cryo-EM technical improvements. Those structures will help better understand the process of translation initiation in eukaryotes.
Most frequently seen, however, is the eastern or red-spotted newt (Notophthalmus viridescens), whose terrestrial eft form is often encountered on the open, dry forest floor. It has been estimated that salamanders represent the largest class of animal biomass in the Appalachian forests. Frogs and toads are of lesser diversity and abundance, but the wood frog (Rana sylvatica) is, like the eft, commonly encountered on the dry forest floor, while a number of species of small frogs, such as spring peepers (Pseudacris crucifer), enliven the forest with their calls. Salamanders and other amphibians contribute greatly to nutrient cycling through their consumption of small life forms on the forest floor and in aquatic habitats. Although reptiles are less abundant and diverse than amphibians, a number of snakes are conspicuous members of the fauna. One of the largest is the non-venomous black rat snake (Elaphe obsoleta obsoleta), while the common garter snake (Thamnophis sirtalis) is among the smallest but most abundant. The eastern copperhead (Agkistrodon contortrix) and the timber rattler (Crotalus horridus) are venomous pit vipers. There are few lizards, but the broad-headed skink (Eumeces laticeps), at up to 13 in (33 cm) in length, and an excellent climber and swimmer, is one of the largest and most spectacular in appearance and action. The most common turtle is the eastern box turtle (Terrapene carolina carolina), which is found in both upland and lowland forests in the central and southern Appalachians.
== External links == 1P-LSD - Isomer Design 1P-LSD - PsychonautWiki 1P-LSD: Is “Legal Acid” Legit? Is it Safe? - Tripsitter 1P-LSD - Lysergamide Psychedelics - TripSitter 1P-LSD - Psychedelic Science Review
Sources: en.wikipedia.org
No. Cardarine has not received approval for human therapeutic use in major jurisdictions. It remains an investigational compound.
It is classified as a PPARδ agonist on the WADA Prohibited List. Anti-doping laboratories can detect it and its metabolites in urine. Its use is banned in competition and usually out of competition.
Rodent studies reported increased tumor incidence at multiple sites. The human relevance remains uncertain, but the findings contributed to discontinuation of development. No long-term human cancer data are available.
Anti-doping laboratories typically use LC-MS/MS to detect GW501516 and its metabolites in urine. The method is sensitive and can identify the compound at low concentrations. Detection depends on sample timing, metabolism, and the specific assay.